Long-term safety profile and secondary effectiveness of canakinumab in pediatric rheumatic diseases: a single-center experience
Article in Expert Opinion on Drug Safety (August 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Expert Opinion on Drug Safety (August 2024)
Article in RMD Open (February 2024)
Article in La Revue de Médecine Interne (October 2023)